Skip to main content
NVDA+0.76%AAPL+0.97%MSFT+0.10%GOOGL+1.08%AMZN+1.05%TSM+2.70%SPCX+1.95%AVGO+3.39%META-1.00%TSLA+3.51%LLY+0.86%BRK-B-0.56%MU+2.41%SKHY+1.83%WMT-0.84%AMD+4.80%JPM+0.60%V-0.66%XOM-1.59%JNJ+0.80%ASMLa+2.41%MA-0.38%ABBV+0.04%INTC+3.02%1398.HK+2.15%CVX-1.37%0700.HK-0.31%COST-0.89%CSCO+1.76%KO-0.45%ORCL+3.13%UNH+0.36%PG-0.59%BAC+0.43%1816.HK+1.32%3988.HK+0.66%CAT+2.48%DELL+7.81%HD+0.07%PM+0.70%0857.HK-0.98%0939.HK+0.81%AMAT+1.51%AP2d+1.26%GE+2.48%1288.HK+0.60%LRCX+0.52%0005.HK-5.56%NVS+1.12%MS+1.39%USDJPY+0.63%AUDJPY+0.62%NZDMXN+0.56%NZDJPY+0.55%AUDDKK+0.53%EURUSD-0.52%EURAUD-0.51%EURZAR-0.50%EURSEK-0.48%AUDCHF+0.47%EURNZD-0.46%USDCHF+0.46%GBPUSD-0.44%GBPZAR-0.44%GBPAUD-0.43%CADJPY+0.42%GBPTRY+0.41%NZDCHF+0.39%AUDNOK+0.37%GBPNZD-0.36%CHFSEK-0.35%EURCNH-0.32%GBPHKD+0.32%USDMXN+0.31%EURCAD-0.29%GBPMXN-0.28%EURHKD-0.28%EURSGD-0.28%USDDKK+0.27%NZDSGD+0.25%AUDSGD+0.25%CADCHF+0.24%GBPCAD-0.24%SGDJPY+0.23%USDCAD+0.22%USDZAR-0.22%USDSEK-0.22%GBPSGD-0.21%AUDCAD+0.20%CHFJPY+0.18%GBPJPY+0.18%USDTRY+0.18%EURNOK-0.16%USDILS+0.16%USDPLN+0.14%CHFSGD-0.14%NZDCAD+0.13%EURPLN-0.13%EURJPY+0.12%NOKJPY+0.11%USDNOK+0.11%PLNJPY+0.09%USDTHB-0.08%NZDUSD-0.08%EURGBP-0.08%EURCHF-0.08%EURCZK-0.06%AUDNZD+0.06%USDCNH-0.04%USDCOP-0.04%USDHKD+0.04%CHFNOK-0.01%GBPCHF+0.01%USDSGD-0.01%AUDUSD0.00%EURDKK0.00%COFFEE-2.67%HG1+1.53%COTTON-1.28%USOIL-1.06%XAUUSD+1.00%GAUUSD+1.00%UKOIL-0.85%XAGUSD+0.85%GAGUSD+0.85%S1-0.79%XNGUSD-0.67%XPTUSD+0.56%BTCUSD+0.57%ETHUSD+23.96%USDTUSD+0.03%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+4.53%DOGEUSD+20.65%XMRUSDT-1.03%LINKUSD+25.58%BCHUSDT+2.87%XLMUSD+0.03%UNIUSD-0.55%LTCUSD+17.89%SUIUSD+0.67%HBARUSDT-1.72%TONUSD+41.71%TAOUSDT-0.07%AAVEUSD-2.86%DOTUSDT-1.78%ICPUSDT-1.60%ONDOUSDT+0.24%WLDUSDT+0.14%ARBUSDT-0.15%JUPUSDT+0.66%INJUSDT+0.90%ATOMUSDT-0.88%STXUSDT-1.08%TIAUSDT-1.98%PYTHUSDT-3.01%FETUSDT+3.53%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+0.66%OPUSDT-0.20%IOTAUSDT+1.14%WIFUSDT-0.61%POLUSDT-0.30%AXSUSDT+0.41%EOSUSDT+0.92%FARTCOINUSDT+1.91%DYDXUSDT+1.76%GALAUSDT-0.17%ORDIUSDT+1.42%RONINUSDT+1.89%NOTUSDT+1.92%NVDA+0.76%AAPL+0.97%MSFT+0.10%GOOGL+1.08%AMZN+1.05%TSM+2.70%SPCX+1.95%AVGO+3.39%META-1.00%TSLA+3.51%LLY+0.86%BRK-B-0.56%MU+2.41%SKHY+1.83%WMT-0.84%AMD+4.80%JPM+0.60%V-0.66%XOM-1.59%JNJ+0.80%ASMLa+2.41%MA-0.38%ABBV+0.04%INTC+3.02%1398.HK+2.15%CVX-1.37%0700.HK-0.31%COST-0.89%CSCO+1.76%KO-0.45%ORCL+3.13%UNH+0.36%PG-0.59%BAC+0.43%1816.HK+1.32%3988.HK+0.66%CAT+2.48%DELL+7.81%HD+0.07%PM+0.70%0857.HK-0.98%0939.HK+0.81%AMAT+1.51%AP2d+1.26%GE+2.48%1288.HK+0.60%LRCX+0.52%0005.HK-5.56%NVS+1.12%MS+1.39%USDJPY+0.63%AUDJPY+0.62%NZDMXN+0.56%NZDJPY+0.55%AUDDKK+0.53%EURUSD-0.52%EURAUD-0.51%EURZAR-0.50%EURSEK-0.48%AUDCHF+0.47%EURNZD-0.46%USDCHF+0.46%GBPUSD-0.44%GBPZAR-0.44%GBPAUD-0.43%CADJPY+0.42%GBPTRY+0.41%NZDCHF+0.39%AUDNOK+0.37%GBPNZD-0.36%CHFSEK-0.35%EURCNH-0.32%GBPHKD+0.32%USDMXN+0.31%EURCAD-0.29%GBPMXN-0.28%EURHKD-0.28%EURSGD-0.28%USDDKK+0.27%NZDSGD+0.25%AUDSGD+0.25%CADCHF+0.24%GBPCAD-0.24%SGDJPY+0.23%USDCAD+0.22%USDZAR-0.22%USDSEK-0.22%GBPSGD-0.21%AUDCAD+0.20%CHFJPY+0.18%GBPJPY+0.18%USDTRY+0.18%EURNOK-0.16%USDILS+0.16%USDPLN+0.14%CHFSGD-0.14%NZDCAD+0.13%EURPLN-0.13%EURJPY+0.12%NOKJPY+0.11%USDNOK+0.11%PLNJPY+0.09%USDTHB-0.08%NZDUSD-0.08%EURGBP-0.08%EURCHF-0.08%EURCZK-0.06%AUDNZD+0.06%USDCNH-0.04%USDCOP-0.04%USDHKD+0.04%CHFNOK-0.01%GBPCHF+0.01%USDSGD-0.01%AUDUSD0.00%EURDKK0.00%COFFEE-2.67%HG1+1.53%COTTON-1.28%USOIL-1.06%XAUUSD+1.00%GAUUSD+1.00%UKOIL-0.85%XAGUSD+0.85%GAGUSD+0.85%S1-0.79%XNGUSD-0.67%XPTUSD+0.56%BTCUSD+0.57%ETHUSD+23.96%USDTUSD+0.03%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+4.53%DOGEUSD+20.65%XMRUSDT-1.03%LINKUSD+25.58%BCHUSDT+2.87%XLMUSD+0.03%UNIUSD-0.55%LTCUSD+17.89%SUIUSD+0.67%HBARUSDT-1.72%TONUSD+41.71%TAOUSDT-0.07%AAVEUSD-2.86%DOTUSDT-1.78%ICPUSDT-1.60%ONDOUSDT+0.24%WLDUSDT+0.14%ARBUSDT-0.15%JUPUSDT+0.66%INJUSDT+0.90%ATOMUSDT-0.88%STXUSDT-1.08%TIAUSDT-1.98%PYTHUSDT-3.01%FETUSDT+3.53%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+0.66%OPUSDT-0.20%IOTAUSDT+1.14%WIFUSDT-0.61%POLUSDT-0.30%AXSUSDT+0.41%EOSUSDT+0.92%FARTCOINUSDT+1.91%DYDXUSDT+1.76%GALAUSDT-0.17%ORDIUSDT+1.42%RONINUSDT+1.89%NOTUSDT+1.92%
RX

RxSight, Inc. (RXST)

NASDAQ • Healthcare

$4.93
-$0.08 (-1.8%)
Market open

Last close at October 26, 2026 at 20:00 UTC

Open$4.97
Previous Close$4.93
Day Range$4.89 - $5.1
Avg. Volume (3M)668K
Market Cap$205.6M
52 Week Range
$4.4$13.22
Next EarningsIn 7 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$33.7M100%
Gross Profitminus cost of goods$25.8M77%

In plain terms: out of every $100 in revenue, RxSight, Inc. currently loses $36.

Fundamentals & Financials

Revenue (TTM)
$127.5M
Net Income (TTM)
-$46.9M
EPS (TTM)
-$1.13
ROA (TTM)
-13.31%
Current Ratio
4.07

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+34.3%Q1 2026-$0.22
-27.1%Q2 2026-$0.38
+12.0%Q3 2026-$0.29
Next

Nov 3

in 7 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +12.0%

RxSight topped consensus on both revenue and EPS in the second fiscal quarter of 2026, reported August 5, 2026, with revenue essentially flat year over year, up 0.3% to about $33.7 million. Revenue of $33.7 million topped the $32.5 million estimate, +3.7%, while EPS of -$0.29 topped the -$0.33 estimate by $0.04 and was essentially unchanged from a year ago. Profitability remained defined by high gross margin and operating losses, as gross profit was roughly $25.9 million and gross margin held near 77%, while operating income was about -$13.8 million for an operating margin of roughly -41%. Net income was about -$12.1 million, down 2.6% from a year ago, reflecting a similar loss profile versus last year’s quarter. Cash generation was also negative, with negative operating cash flow of about -$9.5 million. For the next period, consensus calls for EPS of -$0.29 on revenue of $27.2 million.

Next report — what to expect

RxSight, Inc. (RXST) reports on November 4, 2026. Wall Street’s consensus calls for EPS of -$0.29 on revenue of $27.2 million. For trailing context, revenue grew +0.3% year over year last quarter. RXST has beaten EPS in 6 of 8 most recent quarters.

View full earnings history

About RxSight, Inc.

RxSight, Inc. develops and sells ophthalmic technology for cataract care and trades on the NASDAQ under RXST. The healthcare company focuses on medical devices centered on light-adjustable intraocular lenses, and it generated $134.5 million of revenue in FY2025 through lens and device sales for cataract procedures.

Name
RxSight, Inc.
CEO
Aziz Mottiwala
Website
www.rxsight.com
Industry
Healthcare
Year Founded
1997
Employees
461

Today's Snapshot

AI-generated

The session opened with RXST slightly higher at 4.95, while its sector was flat. Earnings are due from RXST on 3 November.

Trading Volume

Below 10d avg (546.3K)

40.1K

vs S&P 500 Today

Outperforming Market

+0.54%

Updated: October 27, 2026 at 14:46 UTC

Technical Indicators

2 Buy3 Neutral3 Sell
RXST trades at about 4.94 amid a broadly mixed backdrop that supports a neutral stance. Short-term averages sit below the current price and show modest bullishness while medium- and long-term averages remain higher, creating a split pattern; MACD is near neutral and RSI is midrange around 48, reflecting limited momentum. ADX is low, indicating a weak trend, and OBV is negative, suggesting caution on volume. The classic pivot at 4.97 is close to the market and not definitive. Technical takeaway: Neutral.
All signals
  • EMA (5 indicators)$4.87 - $6.81
    Sell
  • RSI (14)48.52
    Neutral
  • Stochastic %K (14, 3, 3)79.34
    Neutral
  • MACD Level (12, 26)-0.11
    Neutral

Peers & Related Assets

BFLYButterfly Network, Inc.
$6.66-1.5%
KIDSOrthoPediatrics Corp.
$24.02-2.0%
TCMDTactile Systems Technology, Inc.
$23.39-1.1%
CERSCerus Corporation
$2.37+1.7%
NPCENeuroPace, Inc.
$12.99+0.6%
TMCITreace Medical Concepts, Inc.
$4.42+3.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.